Animal-Derived Surfactants Versus Past and Current Synthetic Surfactants: Current Status

Jobe, 2006, Why surfactant works for respiratory distress syndrome, NeoReviews, 7, 95, 10.1542/neo.7-2-e95 Yost CC, Soll RF. Early versus delayed selective surfactant treatment for neonatal respiratory distress syndrome. Cochrane Database Syst Rev 2000;(2):CD001456. Soll RF, Morley CJ. Prophylactic versus selective use of surfactant in preventing morbidity and mortality in preterm infants. Cochrane Database Syst Rev 2001;(2):CD000510. Halliday, 2006, Recent clinical trials of surfactant treatment for neonates, Biol Neonate, 89, 323, 10.1159/000092869 Soll RF, Blanco F. Natural surfactant extract versus synthetic surfactant for neonatal respiratory distress syndrome. Cochrane Database Syst Rev 2001;(2):CD000144. Horbar, 1993, A multicenter randomized trial comparing two surfactants for the treatment of neonatal respiratory distress syndrome, J Pediatr, 123, 757, 10.1016/S0022-3476(05)80856-X Sehgal, 1994, Modified bovine surfactant (Survanta) versus a protein-free surfactant (Exosurf) in the treatment of respiratory distress syndrome in preterm infants: a pilot study, J Natl Med Assoc, 86, 46 Vermont-Oxford Neonatal Network, 1996, A multicenter, randomized trial comparing synthetic surfactant with modified bovine surfactant extract in the treatment of neonatal respiratory distress syndrome, Pediatrics, 97, 1 Modanlou, 1997, Comparative efficacy of Exosurf and Survanta surfactants on early clinical course of respiratory distress syndrome and complications of prematurity, J Perinatol, 17, 455 da Costa, 1999, Comparative trial of artificial and natural surfactants in the treatment of respiratory distress syndrome of prematurity: experiences in a developing county, Pediatr Pulmonol, 27, 312, 10.1002/(SICI)1099-0496(199905)27:5<312::AID-PPUL3>3.0.CO;2-N Hudak, 1996, A multicenter randomized, masked comparison trial of natural versus synthetic surfactant for the treatment of respiratory distress syndrome, J Pediatr, 128, 396, 10.1016/S0022-3476(96)70291-3 Hudak, 1997, A multicenter randomized masked comparison trial of synthetic surfactant versus calf lung surfactant extract in the prevention of neonatal respiratory distress syndrome, Pediatrics, 100, 39, 10.1542/peds.100.1.39 Kukkonen, 2000, Randomized trial comparing natural and synthetic surfactant: increased infection rate after natural surfactant?, Acta Paediatr, 89, 556, 10.1111/j.1651-2227.2000.tb00328.x Ainsworth, 2000, Pumactant and poractant alfa for treatment of respiratory distress syndrome in neonates born at 25-29 weeks' gestation: a randomised trial, Lancet, 355, 1387, 10.1016/S0140-6736(00)02136-X Jadad, 1996, Assessing the quality of reports of randomized clinical trials: is blinding necessary?, Control Clin Trials, 17, 1, 10.1016/0197-2456(95)00134-4 Moya, 2005, A multicenter, randomized, masked, comparison trial of lucinactant, colfosceril palmitate and beractant for the prevention of respiratory distress syndrome among very preterm infants, Pediatrics, 115, 1018, 10.1542/peds.2004-2183 Hall, 1992, Importance of hydrophobic apoproteins as constituents of clinical exogenous surfactants, Am Rev Respir Dis, 145, 24, 10.1164/ajrccm/145.1.24 Cummings, 1992, A controlled clinical comparison of four different surfactant preparations in surfactant-deficient preterm lambs, Am Rev Respir Dis, 145, 999, 10.1164/ajrccm/145.5.999 Bloom, 1997, Comparison of Infasurf (calf lung surfactant extract) to Survanta (beractant) in the treatment and prevention of respiratory distress syndrome, Pediatrics, 100, 31, 10.1542/peds.100.1.31 Attar, 2004, Immediate changes in lung compliance following natural surfactant administration in premature infants with respiratory distress syndrome: a controlled trial, J Perinatol, 24, 626, 10.1038/sj.jp.7211160 Bloom, 2005, Comparison of Infasurf (calfactant) and Survanta (beractant) in the prevention and treatment of respiratory distress syndrome, Pediatrics, 116, 392, 10.1542/peds.2004-2783 Baroutis, 2003, Comparison of three treatment regimens of natural surfactant preparations in neonatal respiratory distress syndrome, Eur J Pediatr, 162, 476, 10.1007/s00431-002-1144-0 Hammoud, 2004, Randomized clinical trial comparing two natural surfactant preparations to treat respiratory distress syndrome, J Matern Fetal Neonatal Med, 15, 167, 10.1080/14767050410001668266 Yalaz, 2004, A comparison of efficacy between two natural exogenous surfactant preparations in premature infants with respiratory distress syndrome, Klin Pädiatr, 216, 230, 10.1055/s-2004-44899 Speer, 1995, Randomised clinical trial of two treatment regimens of natural surfactant preparations in neonatal respiratory distress syndrome, Arch Dis Child, 72, F8, 10.1136/fn.72.1.F8 Ramanathan, 2004, A randomized, multicenter masked comparison trial of poractant alfa (Curosurf) versus beractant (Survanta) in the treatment of respiratory distress syndrome in preterm infants, Am J Perinatol, 21, 109, 10.1055/s-2004-823779 Malloy, 2005, A randomized trial comparing beractant and poractant treatment in neonatal respiratory distress syndrome, Acta Paediatr, 94, 779, 10.1080/08035250510028740 Murdoch, 2000, The effects of synthetic and natural surfactant on fluid balance in acute respiratory distress syndrome, Eur J Pediatr, 159, 767, 10.1007/PL00008343 Cochrane, 1991, Pulmonary surfactant protein B (SP-B): structure-function relationships, Science, 254, 566, 10.1126/science.1948032 Revak, 1996, Efficacy of synthetic peptide-containing surfactant in the treatment of respiratory distress syndrome in preterm infant rhesus monkeys, Pediatr Res, 39, 715 Kinniry, 2006, KL4-surfactant prevents hyperoxic and LPS-induced lung injury in mice, Pediatr Pulmonol, 41, 916, 10.1002/ppul.20468 Sinha, 2005, A multicenter, randomized, controlled trial of lucinactant versus poractant alfa among very premature infants at high risk for respiratory distress syndrome, Pediatrics, 115, 1030, 10.1542/peds.2004-2231